Arkema SA (OTCMKTS:ARKAY – Get Free Report) was the target of a large increase in short interest in July. As of July 15th, there was short interest totaling 1,729 shares, an increase of 559.9% from the June 30th total of 262 shares. Currently, 0.0% of the company’s stock are sold short. Based on an average daily volume of 3,426 shares, the days-to-cover ratio is currently 0.5 days.
Arkema Trading Up 0.8%
OTCMKTS ARKAY opened at $63.54 on Friday. The company has a debt-to-equity ratio of 0.53, a quick ratio of 1.64 and a current ratio of 2.25. Arkema has a one year low of $56.28 and a one year high of $79.36. The company has a 50-day simple moving average of $66.23 and a 200-day simple moving average of $66.99. The firm has a market capitalization of $4.83 billion, a PE ratio of 254.15 and a beta of 0.86.
Arkema (OTCMKTS:ARKAY – Get Free Report) last released its quarterly earnings data on Wednesday, May 6th. The basic materials company reported $1.01 earnings per share for the quarter, topping the consensus estimate of $0.91 by $0.10. Arkema had a net margin of 0.46% and a return on equity of 4.06%. The firm had revenue of $2.57 billion for the quarter, compared to analyst estimates of $2.52 billion. On average, equities analysts forecast that Arkema will post 3.48 earnings per share for the current year.
Wall Street Analysts Forecast Growth
Get Our Latest Research Report on ARKAY
About Arkema
Arkema SA is a global specialty chemicals and advanced materials company headquartered in Colombes, France. Established in 2004 as a spin-off from Total’s chemicals division, the company offers a broad portfolio of high-performance materials designed to improve durability, thermal and chemical resistance, and environmental performance across diverse industries.
Arkema’s operations are organized into four core segments. Adhesive Solutions delivers bonding, sealing, and coating technologies for markets such as packaging, medical devices, and consumer goods.
Featured Stories
- Five stocks we like better than Arkema
- AMD and Cerbras Create A New Blueprint For Hardware
- Intel Earnings Reveal Whether the Chip Selloff Created a Buy
- CrowdStrike’s Cerebras Deal Puts Its AI Security Strategy to the Test
- Plugging In: How Kinder Morgan Powers Up Profits
Receive News & Ratings for Arkema Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arkema and related companies with MarketBeat.com's FREE daily email newsletter.
